EP1635809A1 - Resolution de derives d'acide alpha-(phenoxy)phenylacetique - Google Patents
Resolution de derives d'acide alpha-(phenoxy)phenylacetiqueInfo
- Publication number
- EP1635809A1 EP1635809A1 EP04755657A EP04755657A EP1635809A1 EP 1635809 A1 EP1635809 A1 EP 1635809A1 EP 04755657 A EP04755657 A EP 04755657A EP 04755657 A EP04755657 A EP 04755657A EP 1635809 A1 EP1635809 A1 EP 1635809A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- cpta
- phenoxy
- enantiomer
- phenylacetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60018903A | 2003-06-20 | 2003-06-20 | |
US10/656,567 US7199259B2 (en) | 2003-06-20 | 2003-09-04 | Resolution of α-(phenoxy)phenylacetic acid derivatives |
PCT/US2004/019616 WO2004112774A1 (fr) | 2003-06-20 | 2004-06-18 | Resolution de derives d'acide ?lpha-(phenoxy)phenylacetique |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1635809A1 true EP1635809A1 (fr) | 2006-03-22 |
EP1635809A4 EP1635809A4 (fr) | 2006-09-27 |
Family
ID=33544772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04755657A Withdrawn EP1635809A4 (fr) | 2003-06-20 | 2004-06-18 | Resolution de derives d'acide alpha-(phenoxy)phenylacetique |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1635809A4 (fr) |
KR (1) | KR101073742B1 (fr) |
CA (1) | CA2529774C (fr) |
IL (1) | IL172663A0 (fr) |
MX (1) | MXPA05013981A (fr) |
RS (1) | RS20050937A (fr) |
WO (1) | WO2004112774A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7576131B2 (en) | 1999-06-04 | 2009-08-18 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
US6262118B1 (en) | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
US7199259B2 (en) | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
US20080194646A1 (en) * | 2005-03-21 | 2008-08-14 | Sanders Martin E | Methods For Avoiding Edema in the Treatment of Metabolic, Inflammatory, and Cardiovascular Disorders |
KR100678287B1 (ko) * | 2005-06-23 | 2007-02-02 | 한미약품 주식회사 | 클로피도그렐의 제조방법 및 이에 사용되는 중간체 |
US7714131B2 (en) * | 2005-09-23 | 2010-05-11 | Metabolex, Inc. | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1182008A (en) * | 1966-10-03 | 1970-02-25 | Merck & Co Inc | Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid |
US3517050A (en) * | 1966-10-03 | 1970-06-23 | Merck & Co Inc | Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid |
WO2002044113A2 (fr) * | 2000-11-28 | 2002-06-06 | Metabolex, Inc. | Utilisation de derives d'acide acetique(-)(3-halomethylphenoxy)(4-halophenyl) dans le traitement de la resistance a l'insuline, le diabete de type 2, l'hyperlipidemie et l'hyperuricemie |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
-
2004
- 2004-06-18 RS YUP-2005/0937A patent/RS20050937A/sr unknown
- 2004-06-18 WO PCT/US2004/019616 patent/WO2004112774A1/fr active Application Filing
- 2004-06-18 CA CA2529774A patent/CA2529774C/fr not_active Expired - Fee Related
- 2004-06-18 MX MXPA05013981A patent/MXPA05013981A/es active IP Right Grant
- 2004-06-18 EP EP04755657A patent/EP1635809A4/fr not_active Withdrawn
-
2005
- 2005-12-18 IL IL172663A patent/IL172663A0/en unknown
- 2005-12-20 KR KR1020057024492A patent/KR101073742B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1182008A (en) * | 1966-10-03 | 1970-02-25 | Merck & Co Inc | Resolution of d1-(3-Trifluoromethylphenoxy)-(4-Chlorophenyl)Acetic Acid |
US3517050A (en) * | 1966-10-03 | 1970-06-23 | Merck & Co Inc | Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid |
WO2002044113A2 (fr) * | 2000-11-28 | 2002-06-06 | Metabolex, Inc. | Utilisation de derives d'acide acetique(-)(3-halomethylphenoxy)(4-halophenyl) dans le traitement de la resistance a l'insuline, le diabete de type 2, l'hyperlipidemie et l'hyperuricemie |
Non-Patent Citations (1)
Title |
---|
See also references of WO2004112774A1 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA05013981A (es) | 2006-03-02 |
KR101073742B1 (ko) | 2011-10-13 |
RS20050937A (en) | 2008-04-04 |
CA2529774A1 (fr) | 2004-12-29 |
EP1635809A4 (fr) | 2006-09-27 |
WO2004112774A1 (fr) | 2004-12-29 |
IL172663A0 (en) | 2006-04-10 |
KR20060030048A (ko) | 2006-04-07 |
CA2529774C (fr) | 2014-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070203243A1 (en) | Resolution of alpha-(phenoxy) phenylacetic acid derivatives | |
CA2623355C (fr) | Resolution de derives d'acide alpha-(phenoxy) phenylacetique avec des naphtyl-alkylamines | |
US20080293965A1 (en) | Process for the Dynamic Resolution of (Substituted) (R)- or (S)- Mandelic Acid | |
KR101073742B1 (ko) | α-(페녹시)페닐아세트산 유도체의 분리 | |
MXPA02005321A (es) | Nuevo proceso para la preparacion de intermediarios enantiomericamente enriquecidos. | |
CA2623350C (fr) | Procede de preparation stereoselective de (-)-halofenates et d'intermediaires de ces derniers | |
US5574183A (en) | Preparation of optically active aliphatic carboxylic acids | |
JPH05229986A (ja) | 2−(4−イソブチルフェニル)プロピオン酸の光学分割方法 | |
US6812363B2 (en) | Racemization of optically active 2-substituted phenyl glycine esters | |
US7619085B2 (en) | Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine | |
CN100525757C (zh) | α-(苯氧基)苯乙酸衍生物的拆分 | |
US5977391A (en) | (+)- and (-) -8-halogen-6- hydroxy-octanoic acid its salts and esters and process for making | |
US5869713A (en) | (+)- or (-) -8-halogen-6-hydroxy-octanoic acid, its salts and esters, and process for making | |
US5041620A (en) | Method for producing optically active 2-cyclopenten-4-one-1-ol esters, 2-cyclopenteno-4-one-1-ol ester and complexes thereof with optically active 1,6-diphenyl-2,4-hexadiyne-1,6-diol | |
JP2003238506A (ja) | 光学活性なβ−フェニルアラニン誘導体の製造方法 | |
JPH0267237A (ja) | 光学活性1,1,1−トリフルオロ−2−アルカノールの製造法 | |
JPH07215922A (ja) | 1−アミノ−2−インダノール類の光学分割法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: HR MK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060830 |
|
RAX | Requested extension states of the european patent have changed |
Extension state: MK Payment date: 20051223 Extension state: HR Payment date: 20051223 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20101231 |